(Q67489965)

English

A randomized prospective study of cisplatin and vinblastine versus cisplatin, vinblastine and mitomycin in advanced non-small cell lung cancer

scientific article published on 01 February 1992

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1318742%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

A randomized prospective study of cisplatin and vinblastine versus cisplatin, vinblastine and mitomycin in advanced non-small cell lung cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1318742%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

non-small-cell lung carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058127

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058127

5 December 2023

author name string

N. Mylonakis

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1318742

12 September 2022

N. Tsavaris

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1318742

12 September 2022

C. Bacoyiannis

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1318742

12 September 2022

N. Karvounis

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1318742

12 September 2022

S. Kakolyris

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1318742

12 September 2022

A. Karabelis

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1318742

12 September 2022

M. Beer

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1318742

12 September 2022

P. Kosmidis

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1318742

12 September 2022

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1318742

12 September 2022

publication date

1 February 1992

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1318742%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

full work available at URL

http://annonc.oxfordjournals.org/cgi/content/abstract/3/2/127

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1318742

12 September 2022

https://doi.org/10.1093/oxfordjournals.annonc.a058127

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1318742

5 December 2023

https://api.elsevier.com/content/article/PII:S0923753419651562?httpAccept=text/xml

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058127

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058127

5 December 2023

https://api.elsevier.com/content/article/PII:S0923753419651562?httpAccept=text/plain

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058127

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058127

5 December 2023

http://academic.oup.com/annonc/article-pdf/3/2/127/530556/3-2-127.pdf

Portable Document Format

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058127

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058127

5 December 2023

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1318742%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1318742%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1318742%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

127-130

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1318742%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

Efficacy study of intensive cis-platin therapy in advanced non-small cell bronchogenic carcinoma

1

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058127

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058127

5 December 2023

Mitomycin C in advanced adenocarcinoma and large cell carcinoma of the lung

6

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058127

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058127

5 December 2023

Random prospective study of vindesine versus vindesine plus high-dose cisplatin versus vindesine plus cisplatin plus mitomycin C in advanced non-small-cell lung cancer

7

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058127

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058127

5 December 2023

Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: A randomized study

8

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058127

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058127

5 December 2023

Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessment

9

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058127

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058127

5 December 2023

Combination chemotherapy confers modest survival advantage in patients with advanced non-small cell lung cancer: report of a Canadian multicenter randomized trial

12

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058127

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058127

5 December 2023

Phase II trial of mitomycin, vinblastine, and cisplatin (MVP) in non-small cell bronchogenic carcinoma

13

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058127

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058127

5 December 2023

Combination chemotherapy with mitomycin-C, cisplatin, and vinblastine in the treatment of non-small-cell lung cancer

14

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058127

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058127

5 December 2023

Extensive non-small cell lung cancer treated with mitomycin, cisplatin, and vindesine (MiPE): a Southwest Oncology Group Study

15

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058127

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058127

5 December 2023

Chemotherapy for metastatic non-small-cell bronchogenic carcinoma: EST 2575, generation V--a randomized comparison of four cisplatin-containing regimens

17

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058127

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058127

5 December 2023

A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal Meningitis

23

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058127

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058127

5 December 2023

Identifiers

10.1093/OXFORDJOURNALS.ANNONC.A058127

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1318742%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1318742%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q67489965&oldid=2074534261"